Gunnar Telhammar

Hired as a CFO to the company since 2013. Master of Science in Business and Economics, Lund university.

Born:

1961

Gunnar Telhammar

Experience: Has held several positions as CFO, both in Sweden and abroad, and has been operating through his own consulting firm BioFinans AB for over 15 years.

‍Current assignments: CEO of BioFinans AB, CFO of AcouSort AB and ImmuneBiotech AB.

‍Previous assignments: He has previously been CFO of Guard Therapeutics AB and Board member of Targinta AB.

‍Shareholding: 464,828

Other Board Members

Gregory Batcheller

Gregory Batcheller

Chairman of the Board since 2011. LL.M, J.D., B.Sc. (Econ.)

Maarten de Château

Maarten de Château

Board member since 2021. MD, Ph.D.

Thomas Eldered

BOARD MEMBER SINCE 2022. MASTER OF SCIENCE IN INDUSTRIAL ENGINEERING AND MANAGEMENT.

Lars Hedbys

Board member since 2021. Ph.D. in Applied Biochemistry

Hans-Joachim Simons

Hans-Joachim Simons

BOARD MEMBER SINCE 2022. MD, PH.D. ORTHOPAEDIC SPECIALIST AND MBA.

Others in the Management

Evy Lundgren-Åkerlund

Evy Lundgren-Åkerlund

Chief Executive Officer since 2009. Doctor of Medical Science, senior lecturer.

Gregory Batcheller

Gregory Batcheller

Chairman of the Board since 2011. LL.M, J.D., B.Sc. (Econ.)

Camilla Wennersten

Camilla Wennersten

DIRECTOR CLINICAL DEVELOPMENT SINCE 2021. Ph.D.

Liselotte Theorell

Liselotte Theorell

DIRECTOR QUALITY MANAGEMENT SINCE 2017, QP

Lucienne Vonk

CSO SINCE 2024. Ph.D., Associate Professor